[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Anti-inflammatory Serums Market Growth 2024-2030

June 2024 | 117 pages | ID: GA048BD128EFEN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global Anti-inflammatory Serums market size was valued at US$ million in 2023. With growing demand in downstream market, the Anti-inflammatory Serums is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.

The research report highlights the growth potential of the global Anti-inflammatory Serums market. Anti-inflammatory Serums are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Anti-inflammatory Serums. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Anti-inflammatory Serums market.

Anti-inflammatory Serums

Key Features:

The report on Anti-inflammatory Serums market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Anti-inflammatory Serums market. It may include historical data, market segmentation by Type (e.g., CBD, Blue Copper Peptide), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Anti-inflammatory Serums market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Anti-inflammatory Serums market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Anti-inflammatory Serums industry. This include advancements in Anti-inflammatory Serums technology, Anti-inflammatory Serums new entrants, Anti-inflammatory Serums new investment, and other innovations that are shaping the future of Anti-inflammatory Serums.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Anti-inflammatory Serums market. It includes factors influencing customer ' purchasing decisions, preferences for Anti-inflammatory Serums product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Anti-inflammatory Serums market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Anti-inflammatory Serums market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Anti-inflammatory Serums market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Anti-inflammatory Serums industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Anti-inflammatory Serums market.

Market Segmentation:

Anti-inflammatory Serums market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.

Segmentation by type
  • CBD
  • Blue Copper Peptide
  • Resveratrol
  • Others
Segmentation by application
  • Online Retail
  • Offline Retail
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • The Ordinary
  • La Roche-Posay
  • SkinCeutical
  • Medik8
  • Dermalogica
  • Proya
  • Cosmedix
  • ULUKA
  • SAFERO
  • John Jeff
  • Biophyto-genesis
  • PURID
  • UNISKIN
  • Brandfree
Key Questions Addressed in this Report

What is the 10-year outlook for the global Anti-inflammatory Serums market?

What factors are driving Anti-inflammatory Serums market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Anti-inflammatory Serums market opportunities vary by end market size?

How does Anti-inflammatory Serums break out type, application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Anti-inflammatory Serums Annual Sales 2019-2030
  2.1.2 World Current & Future Analysis for Anti-inflammatory Serums by Geographic Region, 2019, 2023 & 2030
  2.1.3 World Current & Future Analysis for Anti-inflammatory Serums by Country/Region, 2019, 2023 & 2030
2.2 Anti-inflammatory Serums Segment by Type
  2.2.1 CBD
  2.2.2 Blue Copper Peptide
  2.2.3 Resveratrol
  2.2.4 Others
2.3 Anti-inflammatory Serums Sales by Type
  2.3.1 Global Anti-inflammatory Serums Sales Market Share by Type (2019-2024)
  2.3.2 Global Anti-inflammatory Serums Revenue and Market Share by Type (2019-2024)
  2.3.3 Global Anti-inflammatory Serums Sale Price by Type (2019-2024)
2.4 Anti-inflammatory Serums Segment by Application
  2.4.1 Online Retail
  2.4.2 Offline Retail
2.5 Anti-inflammatory Serums Sales by Application
  2.5.1 Global Anti-inflammatory Serums Sale Market Share by Application (2019-2024)
  2.5.2 Global Anti-inflammatory Serums Revenue and Market Share by Application (2019-2024)
  2.5.3 Global Anti-inflammatory Serums Sale Price by Application (2019-2024)

3 GLOBAL ANTI-INFLAMMATORY SERUMS BY COMPANY

3.1 Global Anti-inflammatory Serums Breakdown Data by Company
  3.1.1 Global Anti-inflammatory Serums Annual Sales by Company (2019-2024)
  3.1.2 Global Anti-inflammatory Serums Sales Market Share by Company (2019-2024)
3.2 Global Anti-inflammatory Serums Annual Revenue by Company (2019-2024)
  3.2.1 Global Anti-inflammatory Serums Revenue by Company (2019-2024)
  3.2.2 Global Anti-inflammatory Serums Revenue Market Share by Company (2019-2024)
3.3 Global Anti-inflammatory Serums Sale Price by Company
3.4 Key Manufacturers Anti-inflammatory Serums Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Anti-inflammatory Serums Product Location Distribution
  3.4.2 Players Anti-inflammatory Serums Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR ANTI-INFLAMMATORY SERUMS BY GEOGRAPHIC REGION

4.1 World Historic Anti-inflammatory Serums Market Size by Geographic Region (2019-2024)
  4.1.1 Global Anti-inflammatory Serums Annual Sales by Geographic Region (2019-2024)
  4.1.2 Global Anti-inflammatory Serums Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Anti-inflammatory Serums Market Size by Country/Region (2019-2024)
  4.2.1 Global Anti-inflammatory Serums Annual Sales by Country/Region (2019-2024)
  4.2.2 Global Anti-inflammatory Serums Annual Revenue by Country/Region (2019-2024)
4.3 Americas Anti-inflammatory Serums Sales Growth
4.4 APAC Anti-inflammatory Serums Sales Growth
4.5 Europe Anti-inflammatory Serums Sales Growth
4.6 Middle East & Africa Anti-inflammatory Serums Sales Growth

5 AMERICAS

5.1 Americas Anti-inflammatory Serums Sales by Country
  5.1.1 Americas Anti-inflammatory Serums Sales by Country (2019-2024)
  5.1.2 Americas Anti-inflammatory Serums Revenue by Country (2019-2024)
5.2 Americas Anti-inflammatory Serums Sales by Type
5.3 Americas Anti-inflammatory Serums Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Anti-inflammatory Serums Sales by Region
  6.1.1 APAC Anti-inflammatory Serums Sales by Region (2019-2024)
  6.1.2 APAC Anti-inflammatory Serums Revenue by Region (2019-2024)
6.2 APAC Anti-inflammatory Serums Sales by Type
6.3 APAC Anti-inflammatory Serums Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Anti-inflammatory Serums by Country
  7.1.1 Europe Anti-inflammatory Serums Sales by Country (2019-2024)
  7.1.2 Europe Anti-inflammatory Serums Revenue by Country (2019-2024)
7.2 Europe Anti-inflammatory Serums Sales by Type
7.3 Europe Anti-inflammatory Serums Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Anti-inflammatory Serums by Country
  8.1.1 Middle East & Africa Anti-inflammatory Serums Sales by Country (2019-2024)
  8.1.2 Middle East & Africa Anti-inflammatory Serums Revenue by Country (2019-2024)
8.2 Middle East & Africa Anti-inflammatory Serums Sales by Type
8.3 Middle East & Africa Anti-inflammatory Serums Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-inflammatory Serums
10.3 Manufacturing Process Analysis of Anti-inflammatory Serums
10.4 Industry Chain Structure of Anti-inflammatory Serums

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Anti-inflammatory Serums Distributors
11.3 Anti-inflammatory Serums Customer

12 WORLD FORECAST REVIEW FOR ANTI-INFLAMMATORY SERUMS BY GEOGRAPHIC REGION

12.1 Global Anti-inflammatory Serums Market Size Forecast by Region
  12.1.1 Global Anti-inflammatory Serums Forecast by Region (2025-2030)
  12.1.2 Global Anti-inflammatory Serums Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Anti-inflammatory Serums Forecast by Type
12.7 Global Anti-inflammatory Serums Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 The Ordinary
  13.1.1 The Ordinary Company Information
  13.1.2 The Ordinary Anti-inflammatory Serums Product Portfolios and Specifications
  13.1.3 The Ordinary Anti-inflammatory Serums Sales, Revenue, Price and Gross Margin (2019-2024)
  13.1.4 The Ordinary Main Business Overview
  13.1.5 The Ordinary Latest Developments
13.2 La Roche-Posay
  13.2.1 La Roche-Posay Company Information
  13.2.2 La Roche-Posay Anti-inflammatory Serums Product Portfolios and Specifications
  13.2.3 La Roche-Posay Anti-inflammatory Serums Sales, Revenue, Price and Gross Margin (2019-2024)
  13.2.4 La Roche-Posay Main Business Overview
  13.2.5 La Roche-Posay Latest Developments
13.3 SkinCeutical
  13.3.1 SkinCeutical Company Information
  13.3.2 SkinCeutical Anti-inflammatory Serums Product Portfolios and Specifications
  13.3.3 SkinCeutical Anti-inflammatory Serums Sales, Revenue, Price and Gross Margin (2019-2024)
  13.3.4 SkinCeutical Main Business Overview
  13.3.5 SkinCeutical Latest Developments
13.4 Medik8
  13.4.1 Medik8 Company Information
  13.4.2 Medik8 Anti-inflammatory Serums Product Portfolios and Specifications
  13.4.3 Medik8 Anti-inflammatory Serums Sales, Revenue, Price and Gross Margin (2019-2024)
  13.4.4 Medik8 Main Business Overview
  13.4.5 Medik8 Latest Developments
13.5 Dermalogica
  13.5.1 Dermalogica Company Information
  13.5.2 Dermalogica Anti-inflammatory Serums Product Portfolios and Specifications
  13.5.3 Dermalogica Anti-inflammatory Serums Sales, Revenue, Price and Gross Margin (2019-2024)
  13.5.4 Dermalogica Main Business Overview
  13.5.5 Dermalogica Latest Developments
13.6 Proya
  13.6.1 Proya Company Information
  13.6.2 Proya Anti-inflammatory Serums Product Portfolios and Specifications
  13.6.3 Proya Anti-inflammatory Serums Sales, Revenue, Price and Gross Margin (2019-2024)
  13.6.4 Proya Main Business Overview
  13.6.5 Proya Latest Developments
13.7 Cosmedix
  13.7.1 Cosmedix Company Information
  13.7.2 Cosmedix Anti-inflammatory Serums Product Portfolios and Specifications
  13.7.3 Cosmedix Anti-inflammatory Serums Sales, Revenue, Price and Gross Margin (2019-2024)
  13.7.4 Cosmedix Main Business Overview
  13.7.5 Cosmedix Latest Developments
13.8 ULUKA
  13.8.1 ULUKA Company Information
  13.8.2 ULUKA Anti-inflammatory Serums Product Portfolios and Specifications
  13.8.3 ULUKA Anti-inflammatory Serums Sales, Revenue, Price and Gross Margin (2019-2024)
  13.8.4 ULUKA Main Business Overview
  13.8.5 ULUKA Latest Developments
13.9 SAFERO
  13.9.1 SAFERO Company Information
  13.9.2 SAFERO Anti-inflammatory Serums Product Portfolios and Specifications
  13.9.3 SAFERO Anti-inflammatory Serums Sales, Revenue, Price and Gross Margin (2019-2024)
  13.9.4 SAFERO Main Business Overview
  13.9.5 SAFERO Latest Developments
13.10 John Jeff
  13.10.1 John Jeff Company Information
  13.10.2 John Jeff Anti-inflammatory Serums Product Portfolios and Specifications
  13.10.3 John Jeff Anti-inflammatory Serums Sales, Revenue, Price and Gross Margin (2019-2024)
  13.10.4 John Jeff Main Business Overview
  13.10.5 John Jeff Latest Developments
13.11 Biophyto-genesis
  13.11.1 Biophyto-genesis Company Information
  13.11.2 Biophyto-genesis Anti-inflammatory Serums Product Portfolios and Specifications
  13.11.3 Biophyto-genesis Anti-inflammatory Serums Sales, Revenue, Price and Gross Margin (2019-2024)
  13.11.4 Biophyto-genesis Main Business Overview
  13.11.5 Biophyto-genesis Latest Developments
13.12 PURID
  13.12.1 PURID Company Information
  13.12.2 PURID Anti-inflammatory Serums Product Portfolios and Specifications
  13.12.3 PURID Anti-inflammatory Serums Sales, Revenue, Price and Gross Margin (2019-2024)
  13.12.4 PURID Main Business Overview
  13.12.5 PURID Latest Developments
13.13 UNISKIN
  13.13.1 UNISKIN Company Information
  13.13.2 UNISKIN Anti-inflammatory Serums Product Portfolios and Specifications
  13.13.3 UNISKIN Anti-inflammatory Serums Sales, Revenue, Price and Gross Margin (2019-2024)
  13.13.4 UNISKIN Main Business Overview
  13.13.5 UNISKIN Latest Developments
13.14 Brandfree
  13.14.1 Brandfree Company Information
  13.14.2 Brandfree Anti-inflammatory Serums Product Portfolios and Specifications
  13.14.3 Brandfree Anti-inflammatory Serums Sales, Revenue, Price and Gross Margin (2019-2024)
  13.14.4 Brandfree Main Business Overview
  13.14.5 Brandfree Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. Anti-inflammatory Serums Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Anti-inflammatory Serums Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of CBD
Table 4. Major Players of Blue Copper Peptide
Table 5. Major Players of Resveratrol
Table 6. Major Players of Others
Table 7. Global Anti-inflammatory Serums Sales by Type (2019-2024) & (K Units)
Table 8. Global Anti-inflammatory Serums Sales Market Share by Type (2019-2024)
Table 9. Global Anti-inflammatory Serums Revenue by Type (2019-2024) & ($ million)
Table 10. Global Anti-inflammatory Serums Revenue Market Share by Type (2019-2024)
Table 11. Global Anti-inflammatory Serums Sale Price by Type (2019-2024) & (USD/Unit)
Table 12. Global Anti-inflammatory Serums Sales by Application (2019-2024) & (K Units)
Table 13. Global Anti-inflammatory Serums Sales Market Share by Application (2019-2024)
Table 14. Global Anti-inflammatory Serums Revenue by Application (2019-2024)
Table 15. Global Anti-inflammatory Serums Revenue Market Share by Application (2019-2024)
Table 16. Global Anti-inflammatory Serums Sale Price by Application (2019-2024) & (USD/Unit)
Table 17. Global Anti-inflammatory Serums Sales by Company (2019-2024) & (K Units)
Table 18. Global Anti-inflammatory Serums Sales Market Share by Company (2019-2024)
Table 19. Global Anti-inflammatory Serums Revenue by Company (2019-2024) ($ Millions)
Table 20. Global Anti-inflammatory Serums Revenue Market Share by Company (2019-2024)
Table 21. Global Anti-inflammatory Serums Sale Price by Company (2019-2024) & (USD/Unit)
Table 22. Key Manufacturers Anti-inflammatory Serums Producing Area Distribution and Sales Area
Table 23. Players Anti-inflammatory Serums Products Offered
Table 24. Anti-inflammatory Serums Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Anti-inflammatory Serums Sales by Geographic Region (2019-2024) & (K Units)
Table 28. Global Anti-inflammatory Serums Sales Market Share Geographic Region (2019-2024)
Table 29. Global Anti-inflammatory Serums Revenue by Geographic Region (2019-2024) & ($ millions)
Table 30. Global Anti-inflammatory Serums Revenue Market Share by Geographic Region (2019-2024)
Table 31. Global Anti-inflammatory Serums Sales by Country/Region (2019-2024) & (K Units)
Table 32. Global Anti-inflammatory Serums Sales Market Share by Country/Region (2019-2024)
Table 33. Global Anti-inflammatory Serums Revenue by Country/Region (2019-2024) & ($ millions)
Table 34. Global Anti-inflammatory Serums Revenue Market Share by Country/Region (2019-2024)
Table 35. Americas Anti-inflammatory Serums Sales by Country (2019-2024) & (K Units)
Table 36. Americas Anti-inflammatory Serums Sales Market Share by Country (2019-2024)
Table 37. Americas Anti-inflammatory Serums Revenue by Country (2019-2024) & ($ Millions)
Table 38. Americas Anti-inflammatory Serums Revenue Market Share by Country (2019-2024)
Table 39. Americas Anti-inflammatory Serums Sales by Type (2019-2024) & (K Units)
Table 40. Americas Anti-inflammatory Serums Sales by Application (2019-2024) & (K Units)
Table 41. APAC Anti-inflammatory Serums Sales by Region (2019-2024) & (K Units)
Table 42. APAC Anti-inflammatory Serums Sales Market Share by Region (2019-2024)
Table 43. APAC Anti-inflammatory Serums Revenue by Region (2019-2024) & ($ Millions)
Table 44. APAC Anti-inflammatory Serums Revenue Market Share by Region (2019-2024)
Table 45. APAC Anti-inflammatory Serums Sales by Type (2019-2024) & (K Units)
Table 46. APAC Anti-inflammatory Serums Sales by Application (2019-2024) & (K Units)
Table 47. Europe Anti-inflammatory Serums Sales by Country (2019-2024) & (K Units)
Table 48. Europe Anti-inflammatory Serums Sales Market Share by Country (2019-2024)
Table 49. Europe Anti-inflammatory Serums Revenue by Country (2019-2024) & ($ Millions)
Table 50. Europe Anti-inflammatory Serums Revenue Market Share by Country (2019-2024)
Table 51. Europe Anti-inflammatory Serums Sales by Type (2019-2024) & (K Units)
Table 52. Europe Anti-inflammatory Serums Sales by Application (2019-2024) & (K Units)
Table 53. Middle East & Africa Anti-inflammatory Serums Sales by Country (2019-2024) & (K Units)
Table 54. Middle East & Africa Anti-inflammatory Serums Sales Market Share by Country (2019-2024)
Table 55. Middle East & Africa Anti-inflammatory Serums Revenue by Country (2019-2024) & ($ Millions)
Table 56. Middle East & Africa Anti-inflammatory Serums Revenue Market Share by Country (2019-2024)
Table 57. Middle East & Africa Anti-inflammatory Serums Sales by Type (2019-2024) & (K Units)
Table 58. Middle East & Africa Anti-inflammatory Serums Sales by Application (2019-2024) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Anti-inflammatory Serums
Table 60. Key Market Challenges & Risks of Anti-inflammatory Serums
Table 61. Key Industry Trends of Anti-inflammatory Serums
Table 62. Anti-inflammatory Serums Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Anti-inflammatory Serums Distributors List
Table 65. Anti-inflammatory Serums Customer List
Table 66. Global Anti-inflammatory Serums Sales Forecast by Region (2025-2030) & (K Units)
Table 67. Global Anti-inflammatory Serums Revenue Forecast by Region (2025-2030) & ($ millions)
Table 68. Americas Anti-inflammatory Serums Sales Forecast by Country (2025-2030) & (K Units)
Table 69. Americas Anti-inflammatory Serums Revenue Forecast by Country (2025-2030) & ($ millions)
Table 70. APAC Anti-inflammatory Serums Sales Forecast by Region (2025-2030) & (K Units)
Table 71. APAC Anti-inflammatory Serums Revenue Forecast by Region (2025-2030) & ($ millions)
Table 72. Europe Anti-inflammatory Serums Sales Forecast by Country (2025-2030) & (K Units)
Table 73. Europe Anti-inflammatory Serums Revenue Forecast by Country (2025-2030) & ($ millions)
Table 74. Middle East & Africa Anti-inflammatory Serums Sales Forecast by Country (2025-2030) & (K Units)
Table 75. Middle East & Africa Anti-inflammatory Serums Revenue Forecast by Country (2025-2030) & ($ millions)
Table 76. Global Anti-inflammatory Serums Sales Forecast by Type (2025-2030) & (K Units)
Table 77. Global Anti-inflammatory Serums Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 78. Global Anti-inflammatory Serums Sales Forecast by Application (2025-2030) & (K Units)
Table 79. Global Anti-inflammatory Serums Revenue Forecast by Application (2025-2030) & ($ Millions)
Table 80. The Ordinary Basic Information, Anti-inflammatory Serums Manufacturing Base, Sales Area and Its Competitors
Table 81. The Ordinary Anti-inflammatory Serums Product Portfolios and Specifications
Table 82. The Ordinary Anti-inflammatory Serums Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. The Ordinary Main Business
Table 84. The Ordinary Latest Developments
Table 85. La Roche-Posay Basic Information, Anti-inflammatory Serums Manufacturing Base, Sales Area and Its Competitors
Table 86. La Roche-Posay Anti-inflammatory Serums Product Portfolios and Specifications
Table 87. La Roche-Posay Anti-inflammatory Serums Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. La Roche-Posay Main Business
Table 89. La Roche-Posay Latest Developments
Table 90. SkinCeutical Basic Information, Anti-inflammatory Serums Manufacturing Base, Sales Area and Its Competitors
Table 91. SkinCeutical Anti-inflammatory Serums Product Portfolios and Specifications
Table 92. SkinCeutical Anti-inflammatory Serums Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. SkinCeutical Main Business
Table 94. SkinCeutical Latest Developments
Table 95. Medik8 Basic Information, Anti-inflammatory Serums Manufacturing Base, Sales Area and Its Competitors
Table 96. Medik8 Anti-inflammatory Serums Product Portfolios and Specifications
Table 97. Medik8 Anti-inflammatory Serums Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Medik8 Main Business
Table 99. Medik8 Latest Developments
Table 100. Dermalogica Basic Information, Anti-inflammatory Serums Manufacturing Base, Sales Area and Its Competitors
Table 101. Dermalogica Anti-inflammatory Serums Product Portfolios and Specifications
Table 102. Dermalogica Anti-inflammatory Serums Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Dermalogica Main Business
Table 104. Dermalogica Latest Developments
Table 105. Proya Basic Information, Anti-inflammatory Serums Manufacturing Base, Sales Area and Its Competitors
Table 106. Proya Anti-inflammatory Serums Product Portfolios and Specifications
Table 107. Proya Anti-inflammatory Serums Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Proya Main Business
Table 109. Proya Latest Developments
Table 110. Cosmedix Basic Information, Anti-inflammatory Serums Manufacturing Base, Sales Area and Its Competitors
Table 111. Cosmedix Anti-inflammatory Serums Product Portfolios and Specifications
Table 112. Cosmedix Anti-inflammatory Serums Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Cosmedix Main Business
Table 114. Cosmedix Latest Developments
Table 115. ULUKA Basic Information, Anti-inflammatory Serums Manufacturing Base, Sales Area and Its Competitors
Table 116. ULUKA Anti-inflammatory Serums Product Portfolios and Specifications
Table 117. ULUKA Anti-inflammatory Serums Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. ULUKA Main Business
Table 119. ULUKA Latest Developments
Table 120. SAFERO Basic Information, Anti-inflammatory Serums Manufacturing Base, Sales Area and Its Competitors
Table 121. SAFERO Anti-inflammatory Serums Product Portfolios and Specifications
Table 122. SAFERO Anti-inflammatory Serums Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. SAFERO Main Business
Table 124. SAFERO Latest Developments
Table 125. John Jeff Basic Information, Anti-inflammatory Serums Manufacturing Base, Sales Area and Its Competitors
Table 126. John Jeff Anti-inflammatory Serums Product Portfolios and Specifications
Table 127. John Jeff Anti-inflammatory Serums Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. John Jeff Main Business
Table 129. John Jeff Latest Developments
Table 130. Biophyto-genesis Basic Information, Anti-inflammatory Serums Manufacturing Base, Sales Area and Its Competitors
Table 131. Biophyto-genesis Anti-inflammatory Serums Product Portfolios and Specifications
Table 132. Biophyto-genesis Anti-inflammatory Serums Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Biophyto-genesis Main Business
Table 134. Biophyto-genesis Latest Developments
Table 135. PURID Basic Information, Anti-inflammatory Serums Manufacturing Base, Sales Area and Its Competitors
Table 136. PURID Anti-inflammatory Serums Product Portfolios and Specifications
Table 137. PURID Anti-inflammatory Serums Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. PURID Main Business
Table 139. PURID Latest Developments
Table 140. UNISKIN Basic Information, Anti-inflammatory Serums Manufacturing Base, Sales Area and Its Competitors
Table 141. UNISKIN Anti-inflammatory Serums Product Portfolios and Specifications
Table 142. UNISKIN Anti-inflammatory Serums Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. UNISKIN Main Business
Table 144. UNISKIN Latest Developments
Table 145. Brandfree Basic Information, Anti-inflammatory Serums Manufacturing Base, Sales Area and Its Competitors
Table 146. Brandfree Anti-inflammatory Serums Product Portfolios and Specifications
Table 147. Brandfree Anti-inflammatory Serums Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 148. Brandfree Main Business
Table 149. Brandfree Latest Developments

LIST OF FIGURES

Figure 1. Picture of Anti-inflammatory Serums
Figure 2. Anti-inflammatory Serums Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-inflammatory Serums Sales Growth Rate 2019-2030 (K Units)
Figure 7. Global Anti-inflammatory Serums Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Anti-inflammatory Serums Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of CBD
Figure 10. Product Picture of Blue Copper Peptide
Figure 11. Product Picture of Resveratrol
Figure 12. Product Picture of Others
Figure 13. Global Anti-inflammatory Serums Sales Market Share by Type in 2023
Figure 14. Global Anti-inflammatory Serums Revenue Market Share by Type (2019-2024)
Figure 15. Anti-inflammatory Serums Consumed in Online Retail
Figure 16. Global Anti-inflammatory Serums Market: Online Retail (2019-2024) & (K Units)
Figure 17. Anti-inflammatory Serums Consumed in Offline Retail
Figure 18. Global Anti-inflammatory Serums Market: Offline Retail (2019-2024) & (K Units)
Figure 19. Global Anti-inflammatory Serums Sales Market Share by Application (2023)
Figure 20. Global Anti-inflammatory Serums Revenue Market Share by Application in 2023
Figure 21. Anti-inflammatory Serums Sales Market by Company in 2023 (K Units)
Figure 22. Global Anti-inflammatory Serums Sales Market Share by Company in 2023
Figure 23. Anti-inflammatory Serums Revenue Market by Company in 2023 ($ Million)
Figure 24. Global Anti-inflammatory Serums Revenue Market Share by Company in 2023
Figure 25. Global Anti-inflammatory Serums Sales Market Share by Geographic Region (2019-2024)
Figure 26. Global Anti-inflammatory Serums Revenue Market Share by Geographic Region in 2023
Figure 27. Americas Anti-inflammatory Serums Sales 2019-2024 (K Units)
Figure 28. Americas Anti-inflammatory Serums Revenue 2019-2024 ($ Millions)
Figure 29. APAC Anti-inflammatory Serums Sales 2019-2024 (K Units)
Figure 30. APAC Anti-inflammatory Serums Revenue 2019-2024 ($ Millions)
Figure 31. Europe Anti-inflammatory Serums Sales 2019-2024 (K Units)
Figure 32. Europe Anti-inflammatory Serums Revenue 2019-2024 ($ Millions)
Figure 33. Middle East & Africa Anti-inflammatory Serums Sales 2019-2024 (K Units)
Figure 34. Middle East & Africa Anti-inflammatory Serums Revenue 2019-2024 ($ Millions)
Figure 35. Americas Anti-inflammatory Serums Sales Market Share by Country in 2023
Figure 36. Americas Anti-inflammatory Serums Revenue Market Share by Country in 2023
Figure 37. Americas Anti-inflammatory Serums Sales Market Share by Type (2019-2024)
Figure 38. Americas Anti-inflammatory Serums Sales Market Share by Application (2019-2024)
Figure 39. United States Anti-inflammatory Serums Revenue Growth 2019-2024 ($ Millions)
Figure 40. Canada Anti-inflammatory Serums Revenue Growth 2019-2024 ($ Millions)
Figure 41. Mexico Anti-inflammatory Serums Revenue Growth 2019-2024 ($ Millions)
Figure 42. Brazil Anti-inflammatory Serums Revenue Growth 2019-2024 ($ Millions)
Figure 43. APAC Anti-inflammatory Serums Sales Market Share by Region in 2023
Figure 44. APAC Anti-inflammatory Serums Revenue Market Share by Regions in 2023
Figure 45. APAC Anti-inflammatory Serums Sales Market Share by Type (2019-2024)
Figure 46. APAC Anti-inflammatory Serums Sales Market Share by Application (2019-2024)
Figure 47. China Anti-inflammatory Serums Revenue Growth 2019-2024 ($ Millions)
Figure 48. Japan Anti-inflammatory Serums Revenue Growth 2019-2024 ($ Millions)
Figure 49. South Korea Anti-inflammatory Serums Revenue Growth 2019-2024 ($ Millions)
Figure 50. Southeast Asia Anti-inflammatory Serums Revenue Growth 2019-2024 ($ Millions)
Figure 51. India Anti-inflammatory Serums Revenue Growth 2019-2024 ($ Millions)
Figure 52. Australia Anti-inflammatory Serums Revenue Growth 2019-2024 ($ Millions)
Figure 53. China Taiwan Anti-inflammatory Serums Revenue Growth 2019-2024 ($ Millions)
Figure 54. Europe Anti-inflammatory Serums Sales Market Share by Country in 2023
Figure 55. Europe Anti-inflammatory Serums Revenue Market Share by Country in 2023
Figure 56. Europe Anti-inflammatory Serums Sales Market Share by Type (2019-2024)
Figure 57. Europe Anti-inflammatory Serums Sales Market Share by Application (2019-2024)
Figure 58. Germany Anti-inflammatory Serums Revenue Growth 2019-2024 ($ Millions)
Figure 59. France Anti-inflammatory Serums Revenue Growth 2019-2024 ($ Millions)
Figure 60. UK Anti-inflammatory Serums Revenue Growth 2019-2024 ($ Millions)
Figure 61. Italy Anti-inflammatory Serums Revenue Growth 2019-2024 ($ Millions)
Figure 62. Russia Anti-inflammatory Serums Revenue Growth 2019-2024 ($ Millions)
Figure 63. Middle East & Africa Anti-inflammatory Serums Sales Market Share by Country in 2023
Figure 64. Middle East & Africa Anti-inflammatory Serums Revenue Market Share by Country in 2023
Figure 65. Middle East & Africa Anti-inflammatory Serums Sales Market Share by Type (2019-2024)
Figure 66. Middle East & Africa Anti-inflammatory Serums Sales Market Share by Application (2019-2024)
Figure 67. Egypt Anti-inflammatory Serums Revenue Growth 2019-2024 ($ Millions)
Figure 68. South Africa Anti-inflammatory Serums Revenue Growth 2019-2024 ($ Millions)
Figure 69. Israel Anti-inflammatory Serums Revenue Growth 2019-2024 ($ Millions)
Figure 70. Turkey Anti-inflammatory Serums Revenue Growth 2019-2024 ($ Millions)
Figure 71. GCC Country Anti-inflammatory Serums Revenue Growth 2019-2024 ($ Millions)
Figure 72. Manufacturing Cost Structure Analysis of Anti-inflammatory Serums in 2023
Figure 73. Manufacturing Process Analysis of Anti-inflammatory Serums
Figure 74. Industry Chain Structure of Anti-inflammatory Serums
Figure 75. Channels of Distribution
Figure 76. Global Anti-inflammatory Serums Sales Market Forecast by Region (2025-2030)
Figure 77. Global Anti-inflammatory Serums Revenue Market Share Forecast by Region (2025-2030)
Figure 78. Global Anti-inflammatory Serums Sales Market Share Forecast by Type (2025-2030)
Figure 79. Global Anti-inflammatory Serums Revenue Market Share Forecast by Type (2025-2030)
Figure 80. Global Anti-inflammatory Serums Sales Market Share Forecast by Application (2025-2030)
Figure 81. Global Anti-inflammatory Serums Revenue Market Share Forecast by Application (2025-2030)


More Publications